Caricamento...
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Given the median survival of 15 months after diagnosis, novel treatment strategies are needed for glioblastoma. Beta-blockers have been demonstrated to inhibit angiogenesis and tumor cell proliferation in various cancer types. The aim of this study was to systematically review the evidence on the ef...
Salvato in:
| Pubblicato in: | Neurosurg Rev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035104/ https://ncbi.nlm.nih.gov/pubmed/32172480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10143-020-01277-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|